RadNet Inc. (NASDAQ:RDNT) has been given an average rating of “Buy” by the six analysts that are currently covering the stock, MarketBeat.com reports. Two equities research analysts have rated the stock with a hold rating, one has assigned a buy rating and two have issued a strong buy rating on the company. The average 12-month price objective among brokers that have updated their coverage on the stock in the last year is $14.67.
Several research analysts have issued reports on RDNT shares. Zacks Investment Research upgraded shares of RadNet from a “hold” rating to a “buy” rating and set a $11.00 price target for the company in a report on Thursday, January 4th. BidaskClub upgraded shares of RadNet from a “sell” rating to a “hold” rating in a report on Saturday, January 6th. Jefferies Group set a $14.00 price target on shares of RadNet and gave the stock a “buy” rating in a report on Thursday, March 8th. Raymond James Financial started coverage on shares of RadNet in a report on Wednesday. They set a “strong-buy” rating and a $15.00 price target for the company. Finally, FIX started coverage on shares of RadNet in a report on Wednesday. They set a “strong-buy” rating and a $15.00 price target for the company.
In other news, EVP Norman R. Hames sold 5,000 shares of the firm’s stock in a transaction that occurred on Wednesday, December 20th. The shares were sold at an average price of $9.96, for a total transaction of $49,800.00. Following the completion of the sale, the executive vice president now owns 365,087 shares of the company’s stock, valued at approximately $3,636,266.52. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. Also, insider John V. Crues sold 19,684 shares of the firm’s stock in a transaction that occurred on Tuesday, December 19th. The stock was sold at an average price of $10.01, for a total transaction of $197,036.84. Following the sale, the insider now directly owns 544,097 shares of the company’s stock, valued at approximately $5,446,410.97. The disclosure for this sale can be found here. 9.36% of the stock is currently owned by company insiders.
RadNet (NASDAQ:RDNT) opened at $13.40 on Wednesday. The stock has a market cap of $590.54, a P/E ratio of -1,290,000.00, a P/E/G ratio of 2.67 and a beta of 0.69. RadNet has a fifty-two week low of $5.30 and a fifty-two week high of $13.40. The company has a quick ratio of 1.29, a current ratio of 1.29 and a debt-to-equity ratio of 7.88.
RadNet (NASDAQ:RDNT) last issued its quarterly earnings data on Thursday, March 8th. The medical research company reported $0.13 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.14 by ($0.01). The business had revenue of $235.50 million during the quarter, compared to the consensus estimate of $228.46 million. RadNet had a net margin of 0.01% and a return on equity of 26.66%. The firm’s quarterly revenue was up 4.7% compared to the same quarter last year. During the same quarter last year, the business earned $0.08 EPS. equities analysts expect that RadNet will post 0.58 earnings per share for the current year.
RadNet, Inc is a provider of freestanding, fixed-site outpatient diagnostic imaging services in the United States. As of December 31, 2016, the Company operated directly or indirectly through joint ventures, 305 centers located in California, Delaware, Florida, Maryland, New Jersey, New York and Rhode Island.
Receive News & Ratings for RadNet Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for RadNet and related companies with MarketBeat.com's FREE daily email newsletter.